GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'

First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

Peptide Therapeutics Market Size to Reach USD 82.19 Billion by 2032; Surging Requirements for Targeted Medicines in Oncology Augment Market Expansion - SNS Insider

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

Hamilton O. Smith, Who Made a Biotech Breakthrough, Is Dead at 94

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
Nature

David Baltimore obituary: virologist whose enzyme discovery transformed understanding of cancer and HIV/AIDS

The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.
FMIBlog

Norway Aquaculture Vaccines Market Size and Share Forecast Outlook From 2025 to 2035

Explore trends before investing – request a sample report today! A central growth driver for the Norway Aquaculture Vaccines Market is the nation’s strict sustainability standards, which prioritize ...

Palampur varsity empowers students with cutting-edge DNA tech training

Chaudhary Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya, Palampur, successfully concluded a two-day workshop on ...

David Baltimore: The scientist who transformed biology and ushered in the biotech era

In September, David Baltimore — the scientist who discovered reverse transcriptase, a breakthrough often described as one of ...